53 related articles for article (PubMed ID: 30275196)
1. Up-regulation of Bone Morphogenetic Protein 7 by 2-Hydroxycinnamaldehyde Attenuates HNSCC Cell Invasion.
Kang SM; Kim J; Kang SH; Oh SY; Lee HJ; Kwon BM; Hong SH
Anticancer Res; 2018 Oct; 38(10):5747-5757. PubMed ID: 30275196
[TBL] [Abstract][Full Text] [Related]
2. Oxytocin inhibits head and neck squamous cell carcinoma cell migration by early growth response-1 upregulation.
Kim J; Kang SM; Lee HJ; Choi SY; Hong SH
Anticancer Drugs; 2017 Jul; 28(6):613-622. PubMed ID: 28452807
[TBL] [Abstract][Full Text] [Related]
3. Repression of bone morphogenetic protein 4 by let-7i attenuates mesenchymal migration of head and neck cancer cells.
Yang WH; Lan HY; Tai SK; Yang MH
Biochem Biophys Res Commun; 2013 Mar; 433(1):24-30. PubMed ID: 23454123
[TBL] [Abstract][Full Text] [Related]
4. Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma.
Nakashima T; Yasumatsu R; Kuratomi Y; Masuda M; Kuwano T; Toh S; Umezaki T; Cataltepe S; Silverman GA; Komune S
Head Neck; 2006 Jan; 28(1):24-30. PubMed ID: 16155915
[TBL] [Abstract][Full Text] [Related]
5. JunB promotes cell invasion, migration and distant metastasis of head and neck squamous cell carcinoma.
Hyakusoku H; Sano D; Takahashi H; Hatano T; Isono Y; Shimada S; Ito Y; Myers JN; Oridate N
J Exp Clin Cancer Res; 2016 Jan; 35():6. PubMed ID: 26754630
[TBL] [Abstract][Full Text] [Related]
6. Anti-cancer Effect of Luminacin, a Marine Microbial Extract, in Head and Neck Squamous Cell Carcinoma Progression via Autophagic Cell Death.
Shin YS; Cha HY; Lee BS; Kang SU; Hwang HS; Kwon HC; Kim CH; Choi EC
Cancer Res Treat; 2016 Apr; 48(2):738-52. PubMed ID: 26511816
[TBL] [Abstract][Full Text] [Related]
7. Μolecular impact of bone morphogenetic protein 7, on lung cancer cells and its clinical significance.
Liu Y; Chen J; Yang Y; Zhang L; Jiang WG
Int J Mol Med; 2012 Jun; 29(6):1016-24. PubMed ID: 22447022
[TBL] [Abstract][Full Text] [Related]
8. Tid1 functions as a tumour suppressor in head and neck squamous cell carcinoma.
Chen CY; Chiou SH; Huang CY; Jan CI; Lin SC; Hu WY; Chou SH; Liu CJ; Lo JF
J Pathol; 2009 Nov; 219(3):347-55. PubMed ID: 19681071
[TBL] [Abstract][Full Text] [Related]
9. Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma.
Kinoshita T; Nohata N; Watanabe-Takano H; Yoshino H; Hidaka H; Fujimura L; Fuse M; Yamasaki T; Enokida H; Nakagawa M; Hanazawa T; Okamoto Y; Seki N
Int J Oncol; 2012 Jun; 40(6):1770-8. PubMed ID: 22378351
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole.
Wu Y; Palad AJ; Wasilenko WJ; Blackmore PF; Pincus WA; Schechter GL; Spoonster JR; Kohn EC; Somers KD
Clin Cancer Res; 1997 Nov; 3(11):1915-21. PubMed ID: 9815580
[TBL] [Abstract][Full Text] [Related]
11. BMP7 influences proliferation, migration, and invasion of breast cancer cells.
Alarmo EL; Pärssinen J; Ketolainen JM; Savinainen K; Karhu R; Kallioniemi A
Cancer Lett; 2009 Mar; 275(1):35-43. PubMed ID: 18980801
[TBL] [Abstract][Full Text] [Related]
12. Regulation of tumor progression via the Snail-RKIP signaling pathway by nicotine exposure in head and neck squamous cell carcinoma.
Nieh S; Jao SW; Yang CY; Lin YS; Tseng YH; Liu CL; Lee TY; Liu TY; Chu YH; Chen SF
Head Neck; 2015 Dec; 37(12):1712-21. PubMed ID: 24986226
[TBL] [Abstract][Full Text] [Related]
13. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
[TBL] [Abstract][Full Text] [Related]
14. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T
Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin inhibits Toll-like receptor 4-induced pro-oncogenic function in head and neck squamous cell carcinoma.
Ren G; Hu J; Wang R; Han W; Zhao M; Zhou G; Zhang C; Zhang Z
Oncol Rep; 2014 Jun; 31(6):2804-10. PubMed ID: 24737049
[TBL] [Abstract][Full Text] [Related]
16. Mitigation of Tumor-Associated Fibroblast-Facilitated Head and Neck Cancer Progression With Anti-Hepatocyte Growth Factor Antibody Ficlatuzumab.
Kumar D; Kandl C; Hamilton CD; Shnayder Y; Tsue TT; Kakarala K; Ledgerwood L; Sun XS; Huang HJ; Girod D; Thomas SM
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1133-9. PubMed ID: 26540318
[TBL] [Abstract][Full Text] [Related]
17. [Role of specificity protein 1 in transcription regulation of microRNA-92b in head and neck squamous cell carcinoma].
Fang H; Pang P; Liu FY; Sun CF
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Sep; 52(9):563-568. PubMed ID: 29972923
[No Abstract] [Full Text] [Related]
18. Ah receptor antagonism represses head and neck tumor cell aggressive phenotype.
DiNatale BC; Smith K; John K; Krishnegowda G; Amin SG; Perdew GH
Mol Cancer Res; 2012 Oct; 10(10):1369-79. PubMed ID: 22912337
[TBL] [Abstract][Full Text] [Related]
19. The anticancer mechanism of 2'-hydroxycinnamaldehyde in human head and neck cancer cells.
Ahn SG; Jin YH; Yoon JH; Kim SA
Int J Oncol; 2015 Nov; 47(5):1793-800. PubMed ID: 26352194
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of TRIM24 Stimulates Proliferation and Glucose Metabolism of Head and Neck Squamous Cell Carcinoma.
Wang H; Xue W; Jiang X
Biomed Res Int; 2018; 2018():6142843. PubMed ID: 29862279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
